Your browser doesn't support javascript.
loading
Synchronous occurrence of primary cutaneous B-cell lymphoma and cutaneous Rosai-Dorfman disease in distinct lesions: A unique association.
Roccuzzo, Gabriele; Avallone, Gianluca; Cavallo, Francesco; Mastorino, Luca; Conti, Luca; Fava, Paolo; Tomasini, Carlo; Ribero, Simone; Quaglino, Pietro.
Afiliação
  • Roccuzzo G; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Avallone G; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Cavallo F; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Mastorino L; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Conti L; Department of Medical Sciences, Section of Surgical Pathology, University of Turin, Turin, Italy.
  • Fava P; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Tomasini C; Department of Clinical-Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
  • Ribero S; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Quaglino P; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
J Cutan Pathol ; 51(1): 7-10, 2024 Jan.
Article em En | MEDLINE | ID: mdl-36636954
ABSTRACT
Rosai-Dorfman disease, also known as sinus histiocytosis with massive lymphadenopathy (SHML), is a rare subtype of reactive histiocytosis which is seldom associated with Hodgkin's and non-Hodgkin's lymphomas. To date, the coexistence in the same patient of extra nodal SHML and primary cutaneous B-cell lymphoma (PCBCL) has been reported in the literature, as metachronous diagnosis in the anatomical area of the original PCBCL or synchronous occurrence in the same lesions. However, no data have been published as for synchronous occurrence of the two pathological entities in distinct anatomical sites. Herein, we report the first ever described synchronous occurrence of PCBCL and SHML, detected in distinct lesions, affecting the same patient. The complete resolution of the patient's PCBCL after rituximab treatment and the concomitant regression of SHML suggest that this clinically benign reactive histiocytic proliferation, potentially triggered by the lymphoma microenvironment itself, may take place not only in the site of the PCBCL lesion, but also in other distant areas not directly affected by the primary cutaneous lymphoma.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatopatias / Linfoma não Hodgkin / Histiocitose Sinusal / Linfoma de Células B / Linfoma Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: J Cutan Pathol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatopatias / Linfoma não Hodgkin / Histiocitose Sinusal / Linfoma de Células B / Linfoma Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: J Cutan Pathol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália